Technology areas: Biotechnology & Pharmaceuticals • Transportation, E-Commerce & Mechanical Systems
15 pending office actions • 12 art units • 14 examiners • 0 of 15 (0%) have an AI response strategy ready • 22 patents granted in the last 365 days
Kenvue Brands LLC has 14 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 13 distinct examiners and 11 distinct art units, indicating broad distribution with limited concentration.
WERTZ, ASHLEE ELIZABETH is the busiest examiner, with 2 pending actions. The repeated assignment may support comparison of prosecution positions in those matters, but the wider portfolio requires tailored review by examiner and art unit.
Counsel should maintain a centralized record of disclosure, claim, and prior-art positions so that related applications remain consistent without treating the portfolio as a single examination case.
Based on the USPTO statutory response window for each pending office action. 7 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 7 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 2 (13%) |
| §101 + other | 1 (7%) |
| §103 only | 5 (33%) |
| Double-patenting + other | 2 (13%) |
| Multi-statute (no §101) | 5 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WERTZ, ASHLEE ELIZABETH | 2 | 52.7% | +35.6% |
| GEMBEH, SHIRLEY V | 1 | 63.1% | +33.8% |
| CHANG, VINCENT WEN-LIANG | 1 | 72.8% | +26.1% |
| WEBB III, JAMES L | 1 | 13.9% | +21.9% |
| NIA, FATEMEH ESFANDIARI | 1 | 71.5% | +19.9% |
| WOOD, KIMBERLY T | 1 | 54.8% | +27.6% |
| CHAO, ALLEN | 1 | 60.0% | +0.0% |
| HENSON, DEVIN B | 1 | 65.1% | +43.4% |
| LEWIS, CAMRYN BROOKE | 1 | 8.7% | +18.2% |
| KASSA, TIGABU | 1 | 36.7% | +27.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18386194 | Systems, Methods, Mediums, and Apparatuses for Capturing Medications and Medication Usage | LEWIS, CAMRYN BROOKE | 1d overdue |
| 18585836 | PREMATURE AGING DETECTION USING DYNAMIC FACIAL IMAGING | HENSON, DEVIN B | 7d |
| 17760390 | COMPOSITIONS AND APPLICATIONS THEREOF | MITCHELL, EDWIN COLEMAN | 34d |
| 19105715 | Methods of Improving the Appearance of Skin Afflicted with Eczema | GEMBEH, SHIRLEY V | — |
| 18921163 | Mold Lifecycle and Performance Digitalization | CHANG, VINCENT WEN-LIANG | — |
| 18910170 | RISK ASSESSMENT SYSTEM | WEBB III, JAMES L | — |
| 18892968 | METHOD FOR EVALUATING HOMOGENEITY OF ORAL SUSPENSIONS | NIA, FATEMEH ESFANDIARI | — |
| 18615156 | THERAPEUTIC LIQUID COMPOSITIONS | CHAO, ALLEN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18114950 | Oral Care Compositions | WERTZ, ASHLEE ELIZABETH | 24d overdue |
| 18386194 | Systems, Methods, Mediums, and Apparatuses for Capturing Medications and Medication Usage | LEWIS, CAMRYN BROOKE | 1d overdue |
| 18585836 | PREMATURE AGING DETECTION USING DYNAMIC FACIAL IMAGING | HENSON, DEVIN B | 7d |
| 18114937 | Oral Care Compositions | WERTZ, ASHLEE ELIZABETH | 21d |
| 18552211 | COATED FAMOTIDINE PARTICLE | KASSA, TIGABU | 70d |
| 19105715 | Methods of Improving the Appearance of Skin Afflicted with Eczema | GEMBEH, SHIRLEY V | — |
| 18921163 | Mold Lifecycle and Performance Digitalization | CHANG, VINCENT WEN-LIANG | — |
| 18910170 | RISK ASSESSMENT SYSTEM | WEBB III, JAMES L | — |
| Art Unit | Apps |
|---|---|
| 1622 | 2 |
| 1619 | 2 |
| 1612 | 2 |
| 1615 | 1 |
| 2119 | 1 |
| 3624 | 1 |
| 2855 | 1 |
| 3631 | 1 |
| 3791 | 1 |
| 3683 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19105715 | Methods of Improving the Appearance of Skin Afflicted with Eczema | GEMBEH, SHIRLEY V | 1615 | §102§103 | Non-Final OA | — | Pending | Feb 21, 2025 |
| 18921163 | Mold Lifecycle and Performance Digitalization | CHANG, VINCENT WEN-LIANG | 2119 | §101§103§112 | Non-Final OA | — | Pending | Oct 21, 2024 |
| 18910170 | RISK ASSESSMENT SYSTEM | WEBB III, JAMES L | 3624 | §101 | Non-Final OA | — | Pending | Oct 09, 2024 |
| 18892968 | METHOD FOR EVALUATING HOMOGENEITY OF ORAL SUSPENSIONS | NIA, FATEMEH ESFANDIARI | 2855 | §103§112 | Non-Final OA | — | Pending | Sep 23, 2024 |
| 18733498 | Systems, Methods, And Apparatus For Attaching An Otoscope Using An Angled Clip-On Device | WOOD, KIMBERLY T | 3631 | §103 | Non-Final OA | — | Pending | Jun 04, 2024 |
| 18615156 | THERAPEUTIC LIQUID COMPOSITIONS | CHAO, ALLEN | 1622 | §102§103 | Final Rejection | — | Pending | Mar 25, 2024 |
| 18585836 | PREMATURE AGING DETECTION USING DYNAMIC FACIAL IMAGING | HENSON, DEVIN B | 3791 | §102§103§112 | Final Rejection | 7d | Pending | Feb 23, 2024 |
| 18386194 | Systems, Methods, Mediums, and Apparatuses for Capturing Medications and Medication Usage | LEWIS, CAMRYN BROOKE | 3683 | §101 | Non-Final OA | 1d overdue | Pending | Nov 01, 2023 |
| 18552211 | COATED FAMOTIDINE PARTICLE | KASSA, TIGABU | 1619 | §103 | Non-Final OA | 70d | Pending | Sep 25, 2023 |
| 18322135 | ADVANCED METHOD AND KIT FOR WOUND TREATMENT | BARHAM, BETHANY P | 1611 | §103 | Final Rejection | — | Pending | May 23, 2023 |
| 18114937 | Oral Care Compositions | WERTZ, ASHLEE ELIZABETH | 1612 | §103DP | Final Rejection | 21d | Pending | Feb 27, 2023 |
| 18114950 | Oral Care Compositions | WERTZ, ASHLEE ELIZABETH | 1612 | §103§112DP | Final Rejection | 24d overdue | Pending | Feb 27, 2023 |
| 17933174 | DOSAGE FORMS FOR THE DELIVERY OF A PROBIOTIC | IANNUZO, NATALIE NMN | 1653 | §103 | Final Rejection | — | Pending | Sep 19, 2022 |
| 17760390 | COMPOSITIONS AND APPLICATIONS THEREOF | MITCHELL, EDWIN COLEMAN | 1619 | §103§112Other | Final Rejection | 34d | Pending | Aug 09, 2022 |
| 16446718 | Process For Formation of Emulsion Containing Liquid Crystal Structure | SOROUSH, LAYLA | 1622 | §103 | Final Rejection | 112d overdue | Pending | Jun 20, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialKenvue Brands LLC has 15 pending office actions as of October 2026, spread across 12 art units and 14 examiners.
Ashlee Elizabeth Wertz has the most, with 2 of Kenvue Brands LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
